Dr. Sara Hurvitz with patient

UCLA Jonsson Comprehensive Cancer Center

Dr. Sara Hurvitz (left) led a study at UCLA Jonsson Comprehensive Cancer Center that found adding a drug that inhibits the growth of cancer cells to standard hormone therapy improved overall survival in women with advanced-stage breast cancer.

Download Photo (651.1 kB)